Newsletter
Episode #124 – Alzheimer's, Aduhelm & Medicare: What's Next?

CareTalk

Episode #124 – Alzheimer's, Aduhelm & Medicare: What's Next?

January 18, 2022

Episode #124 – Alzheimer's, Aduhelm & Medicare: What's Next?

Aduhelm was the first new Alzheimer's treatment approved by the FDA in 18 years. However, its approval proved to be exceptionally controversial, as many medical experts and doctors opposed the drug, due to the lack of evidence that it is actually effective in slowing memory loss.

In this episode, John and David discuss how Aduhelm got approved and the polarizing affect it is having on US healthcare as whole.

Visit us at www.caretalkpodcast.com

View this episode on YouTube: https://youtu.be/XGVC0E0XCxA

Follow us on the Health Podcast Network: https://bit.ly/3Glciwj

#healthcareindustry #healthcarepolicy #caretalkpodcast #aduhlem #alzheimers #medicare

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
The Happy Nurse: Sustaining the Health of Nurses with Kay Reynoldson